Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enzon Pharmaceuticals Inc (NASDAQ:ENZN)

0.5099
Delayed Data
As of Apr 29
 -0.0001 / -0.02%
Today’s Change
0.39
Today|||52-Week Range
0.90
-25.29%
Year-to-Date
No recent news for Enzon Pharmaceuticals Inc.

Today’s Trading

Previous close0.51
Today’s open0.51
Day’s range0.50 - 0.51
Volume107,747
Average volume (3 months)219,657
Market cap$22.5M
Dividend yield--
Data as of 3:58pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)-24.62%
Earnings growth (this year)--
Earnings growth (next 5 years)+53.00%
Revenue growth (last year)-44.00%
P/E ratio1.0
Price/Sales1.73
Price/Book1.25

Competitors

 Today’s
change
Today’s
% change
WINTWindtree Therapeutic...-0.07-2.54%
PRPHProPhase Labs Inc-0.05-3.70%
ITUSITUS Corp+0.04+1.44%
SPHSSophiris Bio Inc0.000.00%
Data as of 3:59pm ET, 04/29/2016

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$17.5M
Annual profit (last year)$21.6M
Net profit margin123.95%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Secretary
Andrew D. Rackear
Principal Financial &
Accounting Officer
Richard L. Feinstein
Corporate headquarters
Cranford, New Jersey

Forecasts

Partner Offers

Search for Jobs